Johnson & Johnson
Johnson & Johnson: Partnering with the Biomedical Advanced Research and Development Authority (BARDA) to commit more than $1 billion to coronavirus vaccine research and development.
Produced by Marathon Strategies, an independent PR firm that delivers intelligent communications and research solutions. For information, email Phil Singer at [email protected]